Skip to main content

Advertisement

SpringerLink
Log in

Sentinel Lymph Node Biopsy for DCIS: Are We Approaching Consensus?

  • Editorial
  • Breast Oncology
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Kim T, Giuliano AE, Lyman GH. Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma. Cancer 2006; 106:4–16

    Article  PubMed  Google Scholar 

  2. Cody HS, III. Sentinel lymph node biopsy for breast cancer: does anybody not need one? Ann Surg Oncol 2003; 10:1131–1132

    Article  PubMed  Google Scholar 

  3. Xing Y, Foy M, Cox DD, et al. Meta-analysis of sentinel lymph node biopsy after preoperative chemotherapy in patients with breast cancer. Brit J Surg 2006; 93:539–546

    Article  PubMed  CAS  Google Scholar 

  4. King TA, Ganaraj A, Fey JV, et al. Cytokeratin-positive cells in sentinel lymph nodes in breast cancer are not random events: experience in patients undergoing prophylactic mastectomy. Cancer 2004; 101:926–933

    Article  PubMed  Google Scholar 

  5. Lagios MD, Silverstein MJ. Sentinel node biopsy for patients with DCIS: a dangerous and unwarranted direction. Ann Surg Oncol 2001; 8:275–277

    Article  PubMed  CAS  Google Scholar 

  6. Cody HS, Klauber-DeMore N, Borgen PI, et al. Is it really DCIS? Ann Surg Oncol 2001; 8:617–619

    PubMed  Google Scholar 

  7. Silverstein MJ, Lagios MD, Martino S, et al. Outcome after invasive local recurrence in patients with ductal carcinoma in situ of the breast. J Clin Oncol 1998; 16:1367–1373

    PubMed  CAS  Google Scholar 

  8. Fisher B, Dignam J, Wolmark N, et al. Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from the National Surgical Adjuvant Breast and Bowel Project B-17. J Clin Oncol 1998; 16:441–452

    PubMed  CAS  Google Scholar 

  9. Julien J-P, Bijker N, Fentiman IS, et al. Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomised phase III trial 10853. Lancet 2000; 355:528–533

    Article  PubMed  CAS  Google Scholar 

  10. Leonard GD, Swain SM. Ductal Carcinoma In Situ, Complexities and Challenges. JNCI Cancer Spectrum 2004; 96:906–920

    Article  Google Scholar 

  11. Schwartz GF, Solin LJ, Olivotto IA, et al. The consensus conference on the treatment of in situ ductal carcinoma of the breast, April 22–25, 1999. The Breast Journal 2000; 6:4–13

    Article  Google Scholar 

  12. Pendas S, Dauway E, Giuliano AE et al. Sentinel node biopsy in duct carcinoma in situ patients. Ann Surg Oncol 2000; 7:15–20

    Article  PubMed  CAS  Google Scholar 

  13. Klauber-DeMore N, Tan LK, Liberman L, et al. Sentinel lymph node biopsy: is it indicated in patients with high-risk ductal carcinoma-in-situ and ductal carcinoma-in-situ with microinvasion? Ann Surg Oncol 2000; 7:636–642

    Article  PubMed  CAS  Google Scholar 

  14. Cox CE, Nguyen K, Gray RJ, et al. Importance of lymphatic mapping in ductal carcinoma in situ (DCIS): why map DCIS? Am Surg 2001; 67:513–519

    PubMed  CAS  Google Scholar 

  15. Intra M, Veronesi P, Mazzarol G, et al. Axillary sentinel lymph node biopsy in patients with pure ductal carcinoma in situ of the breast. Arch Surg 2003; 138:309–313

    Article  PubMed  Google Scholar 

  16. Yen TW, Hunt KK, Ross MI, et al. Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: a guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ. J Am Coll Surg 2005; 200:516–526

    Article  PubMed  Google Scholar 

  17. Wilkie C, White L, Dupont E, et al. An update of sentinel lymph node mapping in patients with ductal carcinoma in situ. The American Journal of Surgery 2005; 190:563–566

    Article  Google Scholar 

  18. Tamhane R, Dahlstrom JE, McCallum DD, et al. The clinical significance of cytokeratin-positive cells in lymph nodes at the time of mastectomy from patients with ductal carcinoma-in-situ. Ann Surg Oncol 2002; 9:999–1003

    Article  PubMed  Google Scholar 

  19. Lara JF, Young SM, Velilla RE, et al. The relevance of occult axillary micrometastasis in ductal carcinoma in situ: a clinicopathologic study with long-term follow-up. Cancer 2003; 98:2105–2113

    Article  PubMed  Google Scholar 

  20. 4El-Tamer M, Chun J, Gill M, et al. Incidence and clinical significance of lymph node metastasis detected by cytokeratin immunohistochemical staining in ductal carcinoma in situ. Ann Surg Oncol 2005; 12:254–259

    Article  Google Scholar 

  21. Jackman RJ, Burbank F, Parker SH, et al. Stereotactic breast biopsy of nonpalpable lesions: determinants of ductal carcinoma in situ underestimation rates. Radiology 2001; 218:497–502

    PubMed  CAS  Google Scholar 

  22. Cody HS, III, Klauber-DeMore N, Borgen PI, et al. Is it really duct carcinoma in situ? Ann Surg Oncol 2001; 8:617–619

    Article  PubMed  Google Scholar 

  23. Fisher B, Dignam J, Wolmark N, et al. Tamoxifen in the treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial. Lancet 1999; 353:1993–2000

    Article  PubMed  CAS  Google Scholar 

  24. Fisher B, Jeong JH, Anderson S, et al. Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N Engl J Med 2002; 347:567–575

    Article  PubMed  Google Scholar 

  25. Naik AM, Fey J, Gemignani M, et al. The risk of axillary relapse after sentinel lymph node biopsy for breast cancer is comparable with that of axillary lymph node dissection: a follow-up study of 4008 procedures. Ann Surg 2004; 240:462–468

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Breast Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY, 10021, USA

    Hiram S. Cody III MD

Authors
  1. Hiram S. Cody III MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hiram S. Cody III MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cody, H.S. Sentinel Lymph Node Biopsy for DCIS: Are We Approaching Consensus?. Ann Surg Oncol 14, 2179–2181 (2007). https://doi.org/10.1245/s10434-006-9300-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-006-9300-9

Search

Navigation